We discuss the latest news leak from the DEA regarding the rescheduling of Cannabis from an S1 to S3 drug. This news opens up a wealth of opportunities for the industry. Pablo and Charlie navigate the news and dissect the good and potential hurdles that arise with this rescheduling event.

Follow us on

www.zuanicassociates.com

pablo.zuanic@zuanicgoup.com in

X @420Odysseus

https://www.linkedin.com/company/zuanic-associates-llc